Patients with methylated DNA above 2.73% had a lower overall survival than those with levels below 2.73% and presented a negative trend in terms of leukemia-free survival [ 119 ].
← all excerpts
DNA Methylation Events as Markers for Diagnosis and Management of Acute Myeloid Leukemia and Myelodysplastic Syndrome.
1
—
—